DDInter1371 DDInter299
Oxymetholone is a synthetic anabolic steroid marketed under the brand name Anapolon by Hoffmann La Roche Limitedand used in the treatment of osteoporosis, anaemia, and as an agent to stimulate muscle growth in malnourished or underdeveloped patients. Anabolic-androgenic steroids (AAS), such as oxymetholone, have been abused by bodybuilders and athletes. The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events. In 2009, no producers of oxymetholone were identified worldwide (SRI 2009), but it was available from 14 suppliers, including 8 U.S. suppliers (ChemSources 2009).
Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved carfilzomib in July 2012 for the treatment of adults with relapsed or refractory multiple myeloma as monotherapy or combination therapy.
Carfilzomib {u} (Compound) resembles {v} (Compound) Ritonavir
Carfilzomib {u} (Compound) binds {v} (Gene) PSMB8
Carfilzomib {u} (Compound) is included by {v} (Pharmacologic Class) Proteasome Inhibitors
Carfilzomib {u} (Compound) causes {v} (Side Effect) Headache
Carfilzomib {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tuberculin purified protein derivative
Carfilzomib {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tioguanine
Carfilzomib {u} may lead to a major life threatening interaction when taken with {v} Conestat alfa
Carfilzomib {u} may lead to a major life threatening interaction when taken with {v} Infliximab
Carfilzomib (Compound) resembles Ritonavir (Compound)
Carfilzomib (Compound) binds PSMB8 (Gene)
Carfilzomib (Compound) is included by Proteasome Inhibitors (Pharmacologic Class)
Carfilzomib (Compound) causes Headache (Side Effect)
Carfilzomib may cause a moderate interaction that could exacerbate diseases when taken with Tuberculin purified protein derivative
Carfilzomib may cause a moderate interaction that could exacerbate diseases when taken with Tioguanine
Carfilzomib may lead to a major life threatening interaction when taken with Conestat alfa
Carfilzomib may lead to a major life threatening interaction when taken with Infliximab